Internal Medicine, Medical Oncology · Grand Rapids, MI
NPI
1407030307
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
9
Medicare group memberships
Hospitals
5
Hospital affiliations
145 Michigan St NE Ste 5200
Grand Rapids, MI, 49503
Phone (616) 486-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
458 services
Medicare patients, 2024
159
Average age 73
Drug cost, 2024
$4.6M
1,944 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emerson A Lim was code 99214 (office e&m - established), 192 times for 90 patients. In total Emerson A Lim billed 458 services in 11 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 192 | 90 | $66.30 | $13K |
| 99214 Office E&M - Established | Office | 147 | 56 | $78.87 | $12K |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $99.58 | $2,290 |
| 99204 Office E&M - New | Facility | 20 | 20 | $101.99 | $2,040 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 14 | $56.73 | $1,078 |
| 99213 Office E&M - Established | Facility | 17 | 17 | $44.33 | $754 |
| 99205 Office E&M - New | Facility | 13 | 13 | $122.93 | $1,598 |
By year: 2022 $30K for 346 services; 2023 $43K for 541 services; 2024 $34K for 458 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emerson A Lim prescribed most often to Medicare patients was Prednisone, with 521 prescriptions and refills. In total Emerson A Lim wrote 1,944 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 521 | 596 | 115 | $2,050 |
| Abiraterone Acetate Generic | 504 | 510 | 76 | $1.8M |
| Prochlorperazine Maleate Generic | 98 | 98 | 61 | $1,168 |
| Ondansetron Odt Ondansetron | 81 | 81 | 53 | $667 |
| Dexamethasone Generic | 76 | 77 | 30 | $353 |
| Eliquis Apixaban | 48 | 52 | Under 11 | $30K |
| Xtandi Enzalutamide | 48 | 48 | Under 11 | $686K |
| Bicalutamide Generic | 46 | 46 | 29 | $898 |
| Levothyroxine Sodium Generic | 36 | 59 | Under 11 | $392 |
| Orgovyx Relugolix | 32 | 32 | Under 11 | $84K |
| Inlyta Axitinib | 31 | 31 | Under 11 | $529K |
| Duloxetine Hcl Generic | 27 | 41 | Under 11 | $352 |
| Hydrochlorothiazide Generic | 22 | 36 | Under 11 | $89.69 |
| Cabometyx Cabozantinib S-Malate | 21 | 21 | Under 11 | $535K |
| Potassium Chloride Generic | 20 | 20 | 12 | $436 |
Brand drugs: 242 claims; generic drugs: 1,702 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emerson A Lim $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.